Literature DB >> 10215958

The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patients.

M Suwannuraks1, A Chuansumrit, N Sriudomporn.   

Abstract

Controlling haemorrhage by using a celluloid splint as an adjunctive therapy in patients with bleeding disorders is very beneficial in dental extraction. However, this technique still requires specific replacement therapy. The use of fibrin glue as a local treatment in dental extraction, without the use of any blood product replacement, recommended to improve efficiency in controlling haemorrhage during dental extraction. This method was modified using a combination of celluloid splint and fibrin glue for use in dental extraction in bleeding disorder patients. It was found that this method was effective in controlling bleeding, was cost effective, did not require replacement therapy and posed no risk of viral transmission.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215958

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  4 in total

1.  [In vitro testing of thrombocyte adhesion to different collagenous hemostyptic agents].

Authors:  D Rothamel; F Schwarz; V Stoldt; M Herten; C Kotthaus; J Becker
Journal:  Mund Kiefer Gesichtschir       Date:  2006-05

2.  Efficacy of bubaline blood derived fibrin glue in silk ligature-induced acute periodontitis in Wistar rats.

Authors:  Poranee Banyatworakul; Nopadon Pirarat; Sujin Sirisawadi; Thanaphum Osathanon; Chanin Kalpravidh
Journal:  Vet World       Date:  2021-10-06

Review 3.  Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline.

Authors:  Wobke E M van Dijk; Robert J J van Es; Maria E P Correa; Roger E G Schutgens; Karin P M van Galen
Journal:  TH Open       Date:  2021-09-09

4.  The evaluation of fibrin sealants and tissue adhesives in oral surgery among patients with bleeding disorders.

Authors:  Gülsüm Ak; Esra Alpkılıç Başkırt; Esma Kürklü; Meltem Koray; Hakkı Tanyeri; Bülent Zülfikar
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.